Pseudomonas aeruginosa

An Essential Requirement for the Licensing of New Antibiotics Is the Provision of Data on Efficacy and Safety Obtained From Clinical Trials in Which Patients Are Randomized to Receive Either the Experimental Drug or a Comparator Antibiotic Regarded as a Standard Treatment Option. Preface.

An essential requirement for the licensing of new antibiotics is the provision of data on efficacy and safety obtained from clinical trials in which patients are randomized to receive either the experimental drug or a comparator antibiotic regarded as a… Continue reading

An Engineering Approach to Biomedical Sciences: Advanced Strategies in Drug Delivery Systems Production.

An engineering approach to biomedical sciences: advanced strategies in drug delivery systems production.

Transl Med UniSa. 2012 Sep; 4: 3-11
Barba AA, Dalmoro A, d’Amore M

Development and optimization of novel production techniques for drug delivery systems are fundamental… Continue reading

Enhanced Bactericidal Potency of Nanoliposomes by Modification of the Fusion Activity Between Liposomes and Bacterium.

Enhanced bactericidal potency of nanoliposomes by modification of the fusion activity between liposomes and bacterium.

Int J Nanomedicine. 2013; 8: 2351-2360
Ma Y, Wang Z, Zhao W, Lu T, Wang R, Mei Q, Chen T

Pseudomonas aeruginosa represents a… Continue reading

Induction Chemotherapy in Technically Unresectable Locally Advanced Oral Cavity Cancers: Does It Make a Difference?

Induction chemotherapy in technically unresectable locally advanced oral cavity cancers: Does it make a difference?

Indian J Cancer. 2013 Jan-Mar; 50(1): 1-8
Patil VM, Noronha V, Muddu VK, Gulia S, Bhosale B, Arya S, Juvekar S, Chatturvedi P, Chaukar… Continue reading

Secondary Bacterial Infections of Buruli Ulcer Lesions Before and After Chemotherapy With Streptomycin and Rifampicin.

Secondary bacterial infections of buruli ulcer lesions before and after chemotherapy with streptomycin and rifampicin.

PLoS Negl Trop Dis. 2013 May; 7(5): e2191
Yeboah-Manu D, Kpeli GS, Ruf MT, Asan-Ampah K, Quenin-Fosu K, Owusu-Mireku E, Paintsil A, Lamptey I,… Continue reading

PET Radiopharmaceuticals for Probing Enzymes in the Brain.

PET radiopharmaceuticals for probing enzymes in the brain.

Am J Nucl Med Mol Imaging. 2013; 3(3): 194-216
Holland JP, Cumming P, Vasdev N

Biologically important processes in normal brain function and brain disease involve the action of various protein-based… Continue reading

Anti-Dermatophytic Activity of Marine Sponge, Sigmadocia Carnosa (Dendy) on Clinically Isolated Fungi.

Anti-dermatophytic activity of marine sponge, Sigmadocia carnosa (Dendy) on clinically isolated fungi.

Asian Pac J Trop Biomed. 2012 Aug; 2(8): 635-9
Dhayanithi N, Kumar TA, Kalaiselvam M, Balasubramanian T, Sivakumar N

To screen the anti-fungal effects and find out… Continue reading

Duration of Treatment for Osteoporosis.

Duration of treatment for osteoporosis.

Reumatismo. 2013; 65(1): 22-35
Idolazzi L, Fassio A, Gatti D, Tamanini S, Viapiana O, Rossini M, Adami S

Many treatments for postmenopausal osteoporosis with proven efficacy in lowering fracture risk had become available since… Continue reading

A Systems-Level Approach for Investigating Pseudomonas Aeruginosa Biofilm Formation.

A Systems-Level Approach for Investigating Pseudomonas aeruginosa Biofilm Formation.

PLoS One. 2013; 8(2): e57050
Xu Z, Fang X, Wood TK, Huang ZJ

Prevention of the initiation of biofilm formation is the most important step for combating biofilm-associated pathogens, as… Continue reading

Complete Sequence of Broad-Host-Range Plasmid pNOR-2000 Harbouring the Metallo-?-Lactamase Gene blaVIM-2 From Pseudomonas Aeruginosa.

Complete sequence of broad-host-range plasmid pNOR-2000 harbouring the metallo-?-lactamase gene blaVIM-2 from Pseudomonas aeruginosa.

Filed under: Addiction Rehab

J Antimicrob Chemother. 2013 Jan 25;
Bonnin RA, Poirel L, Nordmann P, Eikmeyer FG, Wibberg D, Pühler A, Schlüter A

OBJECTIVES:… Continue reading